Muco Rhinathiol Enfants (Carbocisteine)

Carbocisteine, the active ingredient in Muco Rhinathiol Enfants, is a mucolytic presented as an oral liquid formulation for oral use. It reduces the viscosity of thick respiratory secretions, helping children clear mucus during cough associated with acute respiratory infections. It is formulated for pediatric patients and complies with European Union pharmacopeial standards.

GNH USA supplies Muco Rhinathiol Enfants as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across markets globally.

Carbocisteine is a mucolytic that acts on thickened respiratory secretions in various acute and chronic airway conditions. - Cough with thick sputum: helps loosen mucus, facilitating expectoration in children. - Acute respiratory tract infections: reduces mucus viscosity to improve airway clearance. - Bronchitis: aids in clearing bronchial secretions, supporting recovery.

Carbocisteine is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Nausea: mild stomach upset. - Vomiting: occasional episodes. - Diarrhea: transient loose stools.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, or swelling. - Angioedema: swelling of face, lips, or throat. - Hepatic enzyme elevation: rare abnormal liver tests.

When using carbocisteine, certain precautions should be observed to ensure safety and effectiveness. - Pregnancy: consult a healthcare professional before use, as safety data are limited. - Breastfeeding: use with caution; monitor infant for possible effects. - Renal impairment: dosage may need adjustment in patients with reduced kidney function. - Pediatric use: administer only as prescribed for the indicated age group. - Drug interactions: review concomitant medications for potential interactions. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Carbocisteine may interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Concurrent use with antitussives containing codeine: may diminish mucociliary clearance. - Combination with other mucolytics: increased risk of gastrointestinal irritation.

Moderate Interactions (Monitor Closely): - Bronchodilators (e.g., salbutamol): monitor respiratory response. - Antibiotics (e.g., macrolides): observe for altered absorption. - Anticoagulants (e.g., warfarin): watch for changes in bleeding tendency.